Stocks and Investing Stocks and Investing
Mon, November 14, 2022

Andrew Berens Maintained (AZN) at Buy with Increased Target to $79 on, Nov 14th, 2022


Published on 2024-10-28 00:09:14 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "AstraZeneca PLC" (AZN) at Buy with Increased Target from $78 to $79 on, Nov 14th, 2022.

Andrew has made no other calls on AZN in the last 4 months.



There is 1 other peer that has a rating on AZN. Out of the 1 peers that are also analyzing AZN, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • John Eade of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $75 on, Monday, August 29th, 2022
Contributing Sources